ImmuCell Statistics
NASDAQ: ICCCHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
10.92-0.27 (-2.41%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ImmuCell by the numbers
ImmuCell has a market capitalization of $99.3 million based on 9.09M shares outstanding. Its trailing P/E ratio is 57.5. The stock trades 6.7% above its 50-day average and 18.9% above its 200-day average.
Average daily trading volume is 13.44K shares, or about $146,798 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ICCC valuation vs. peer median
| Metric | ICCC | Peer median | Difference |
|---|---|---|---|
| Market cap | $99.28M | $5.02M | +1877% |
| Avg. volume | 13.44K | 195.12K | -93% |
Peer median across 8 companies: IMDX, NNNN, VNRX, TRIB, BMRA, CDIO, QCLS, VRAX.
Valuation
- Market cap
- $99.28M
- P/E (TTM)
- 57.47
- Price / sales (latest FY)
- 3.59
- EPS (TTM)
- $0.19
- Shares outstanding
- 9.09M
Price and trading
- Previous close
- 11.19
- Open
- 11.06
- Day range
- 10.31 – 11.25
- 52-week range
- 4.67 – 12.10
- 52-week change
- +133.33%
- Beta
- —
- Volume
- 18.75K
- Average volume
- 13.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 99.28M
- Pe
- 57.47
- Forward Pe
- -99.27
- Eps
- 0.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.10
- Week52 Low
- 4.67
- Avg Volume
- 13,443.00
- Shares Outstanding
- 9.09M
- Ma50
- 10.24
- Ma200
- 9.18
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -9.75%
- Pct From52w Low
- 133.83%